StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
NASDAQ SRNE opened at $0.00 on Friday. Sorrento Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.25. The firm has a 50-day moving average price of $0.01 and a 200 day moving average price of $0.01.
About Sorrento Therapeutics
Read More
- Five stocks we like better than Sorrento Therapeutics
- How to Capture the Benefits of Dividend Increases
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 9/30 – 10/4
- Manufacturing Stocks Investing
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.